Published February 1, 2022
| Version v1
Patent
Open
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
Files
US11234990.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f27a65647e2bc33dcf054cb9114df3ab
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 11234990 B2
- Patent application number
- US 201916596342 A
- Other
- oai:uchicago.tind.io:7400
Dates
- Patent filed
-
2019-10-08